Combating muscle atrophy: emerging therapeutic targets that are fiber‐type‐specific
Inflammation, denervation or decreased insulin signaling activate proteolysis and cause muscle wasting. Pathological conditions like obesity and DMD can also exacerbate atrophy via PGD2–RhoA–ROCK2 signaling. In contrast, exercise, dietary interventions, and pharmacological agents can activate Ca2+/calcineurin–NFAT and AMPK–PGC‐1α–MEF pathways ...
Samrat Chakraborty +2 more
wiley +1 more source
Intracellular amyloidosis in peripheral nerve and skeletal muscle. [PDF]
Grafham GK +6 more
europepmc +1 more source
Axial myopathy: an overlooked feature of muscle diseases.
N. Witting, L. Andersen, J. Vissing
semanticscholar +1 more source
Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.
A. Mammen, E. Tiniakou
semanticscholar +1 more source
Absence of anti–HMG‐CoA reductase autoantibodies in severe self‐limited statin‐related myopathy
J. Floyd +4 more
semanticscholar +1 more source
OXPHOS complex deficiency in congenital myopathy: A systematic review. [PDF]
du Preez MJ +4 more
europepmc +1 more source
Decoding GNE Myopathy: From Molecular Basis to Therapeutic Advances
Wakako Yoshioka +2 more
openalex +1 more source
Proteomic analysis of nemaline myopathy in infants reveals distinct common dysregulated proteins and cellular pathways. [PDF]
Hedberg-Oldfors C +4 more
europepmc +1 more source
Malignant Hyperthermia, Rhabdomyolysis, and Critically Ill Myopathy in the Same Child Require Workup for Muscle Disease. [PDF]
Finsterer J.
europepmc +1 more source

